World of DTC Marketing

JUNE 23, 2021

Therefore, I find it hard to understand how so many physicians could show “strong interest” in prescribing a drug with so many questions vs. answers. Not to mention the $56,000 annual price tag. government. Aduhelm joins a group of drugs that potentially leave patients worse off and much poorer for it.

Drugs 218

Drugs FDA Approval Doctors Doctor 218

pharmaphorum

APRIL 27, 2022

The top-line results showed that Enhertu (trastuzumab deruxtecan) achieved a statistically significant and clinically meaningful improvement in both progression-free survival (PFS) and overall survival (OS) when compared to physicians’ choice of chemo. billion upfront to license rights to the drug in a deal that could be worth up to $6.9

Sales 58

Sales Drugs Antibody Licensing 58

World of DTC Marketing

NOVEMBER 3, 2020

An #NHLBI-funded study put a price tag on American’s bad eating habits: $50 billion a year in health care costs, attributable to cardiometabolic diseases such as heart disease, stroke and type 2 diabetes. However, there is NO excuse for healthcare companies continuing to ignore the consequences.

Pharma Companies 190

Pharma Companies Scientist Medicine Research 190

Pharmaceutical Technology

JULY 14, 2022

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.

Drugs 147

Drugs Medicine Marketing Development 147

Rethinking Clinical Trials

AUGUST 30, 2023

There were 4 clusters with 4-6 physicians each (a mix of attendings and fellows). Tags #pctGR, @Collaboratory1 The post Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS) appeared first on Rethinking Clinical Trials.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

FEBRUARY 9, 2023

Because of rebalancing of physicians, there were more COVID-19 patients in the intervention group. The trial was designed before the COVID-19 pandemic, but it was conducted during the height of the pandemic in New York.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

APRIL 5, 2022

Kimmtrak has launched in the US with an annual price tag of around $400,000 a year, reflecting the small target population, and analysts at GlobalData think that could help drive sales above $100 million – a sizeable figure for a small company like Immunocore with no other approved drugs. ” Image by Pexels from Pixabay .

Sales 52

Sales Protein Drugs Trials 52

XTalks

JULY 12, 2021

Based on our ongoing conversations with prescribing physicians, FDA and patient advocates, we submitted this label update with the goal to further clarify the patient population that was studied across the three Aduhelm clinical trials that supported approval.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

pharmaphorum

JANUARY 31, 2023

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. Trust between patients, physician prescribers, and pharmaceutical companies will be re-established. Patients will live more healthily and take their medications.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

pharmaphorum

JUNE 8, 2021

“Physicians will also be obliged to do regular MRIs on patients to see if they have ARIA reactions, which could be a limitation, as repeated MRIs represent an additional economic burden,” he said. The post FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag appeared first on.

Drugs 98

Drugs Marketing FDA Approval Trials 98

Delveinsight

JULY 22, 2020

If there is any sudden change in these parameters, the physician will automatically get alert and can take necessary decisions. One simple example is that with the help of IoT physicians can track the impact of drug uptake on disease progression on a real-time basis. The hospital inventory is equipped with tagged sensors.

Doctors 59

Doctors Doctor Marketing Production 59

Rethinking Clinical Trials

FEBRUARY 22, 2023

The study is enrolling people where they are using social media, such as Facebook ads, twitter influencers, tv ads, interviews with print/electronic news outlets, national tv (an appearance on “The Talk” to discuss the study), targeted advertising, physicians, electronic health records. But for outcomes and others you can do virtually.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Nurses 130

Rethinking Clinical Trials

MARCH 21, 2023

Goldberg Distinguished Professor and Chief of Oncology Physician-in-Chief, North Carolina Cancer Hospital Director, Cancer Outcomes Research Program University of North Carolina Slides Keywords Patient-reported outcomes, Oncology, Clinical Trials Key Points Symptoms are common in cancer care. The culture has fundamentally changed.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Rethinking Clinical Trials

AUGUST 28, 2023

The American College of Physicians guideline states that “physicians and patients should treat acute, sub-acute and chronic LBP with non-drug therapies.” The study then evaluates the model’s effectiveness by comparing the intervention to usual medical care.

Trials 130

Trials Research Medicine Doctors 130

Pharmaceutical Technology

JANUARY 27, 2023

However, Andrew Cournoyer, Senior Vice President of PRECISIONvalue, said this may make the process slightly more arduous for patients and physicians. “To Over the last few years, as price tags for drugs have continuously increased, the popularity of risk sharing agreements has been increasing at a rate of 24% annual average growth.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

XTalks

JANUARY 19, 2024

Alpha therapies are most often implemented in metastatic or palliative settings and the authorized user or physician would prescribe an activity, explained Dr. Guarnaschelli. There is a small but real risk of extravasation as well as a known systemic effect with intravenous administration.

DNA 66

DNA Radiology FDA Approval Development 66

Rethinking Clinical Trials

OCTOBER 31, 2023

A lot of participants have worked with their physician to stop a drug so they can participate. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M.

Trials 228

Trials Medicine Research Clinical Trials 228

Pharma Marketing Network

JUNE 8, 2020

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication. So yeah, there is plenty to talk about there.

HR 40

HR Marketing Doctors Doctor 40